EA Series Trust’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

EA Series Trust’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$2.78M	Buy	+12,839	New	+$2.75M	0.1%	299

Other funds holding KRTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EA Series Trust's KRTX Position: Q2 2023 in Review

EA Series Trust opened a new position in Karuna Therapeutics, Inc. Common Stock (KRTX) in Q2 2023: 12,839 shares worth $2.78M. The stake represents 0.1% of the portfolio and ranks #299 among its holdings.

289 funds tracked by Wall St. Rank hold KRTX as of Q2 2023.

EA Series Trust held 12,839 shares of Karuna Therapeutics, Inc. Common Stock worth $2.78M as of Q2 2023.
Karuna Therapeutics, Inc. Common Stock was a new EA Series Trust position in Q2 2023.
Karuna Therapeutics, Inc. Common Stock made up 0.1% of EA Series Trust's portfolio in Q2 2023, its #299 holding.
289 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q2 2023.

Based on EA Series Trust's 13F filing for Q2 2023, filed 27 Jul 2023.